PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q2 2020. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $443,440 | +128.0% | 18,400 | 0.0% | 0.05% | +91.7% |
Q4 2022 | $194,488 | +146.2% | 18,400 | +5.1% | 0.02% | +118.2% |
Q3 2022 | $79,000 | +17.9% | 17,500 | +4.8% | 0.01% | +22.2% |
Q2 2022 | $67,000 | -45.1% | 16,700 | 0.0% | 0.01% | -35.7% |
Q1 2022 | $122,000 | +29.8% | 16,700 | 0.0% | 0.01% | +40.0% |
Q4 2021 | $94,000 | -17.5% | 16,700 | -6.2% | 0.01% | +400.0% |
Q3 2021 | $114,000 | -24.0% | 17,800 | 0.0% | 0.00% | -88.9% |
Q2 2021 | $150,000 | -15.3% | 17,800 | +5.3% | 0.02% | -21.7% |
Q1 2021 | $177,000 | -35.9% | 16,900 | +3.7% | 0.02% | -42.5% |
Q4 2020 | $276,000 | -99.9% | 16,300 | +1.9% | 0.04% | +14.3% |
Q3 2020 | $205,280,000 | +90731.9% | 16,000 | 0.0% | 0.04% | -18.6% |
Q2 2020 | $226,000 | +58.0% | 16,000 | +3.2% | 0.04% | +30.3% |
Q1 2020 | $143,000 | -99.9% | 15,500 | 0.0% | 0.03% | -17.5% |
Q4 2019 | $230,950,000 | +217777.4% | 15,500 | 0.0% | 0.04% | +90.5% |
Q3 2019 | $106,000 | – | 15,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 417,092 | $5,351,000 | 3.22% |
Johnson & Johnson Innovation - JJDC, Inc. | 574,973 | $7,377,000 | 1.48% |
Soleus Capital Management, L.P. | 139,418 | $1,789,000 | 0.95% |
683 Capital Management, LLC | 859,314 | $11,025,000 | 0.81% |
Perceptive Advisors | 4,265,711 | $54,729,000 | 0.80% |
GILDER GAGNON HOWE & CO LLC | 2,151,402 | $27,602,000 | 0.17% |
Virtus ETF Advisers LLC | 21,485 | $276,000 | 0.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 230,873 | $2,962,000 | 0.12% |
Windsor Creek Advisors, LLC | 28,492 | $366,000 | 0.10% |
Newbridge Financial Services Group, Inc. | 6,500 | $83,000 | 0.08% |